United Therapeutics

Latest news

• An 8,300-share sale followed an option exercise by United Therapeutics (UTHR) counsel Paul A. Mahon. (opens in a new tab)

  Stock Titan · Oct 1, 2026

• United Therapeutics Insider Sold Shares Worth $3,926,177, According to a Recent SEC Filing (opens in a new tab)

  marketscreener.com · Oct 1, 2026

• Family trusts sell 1,920 United Therapeutics (UTHR) shares under CEO Rothblatt's trading plan. (opens in a new tab)

  Stock Titan · Oct 1, 2026

• Form 144 UNITED THERAPEUTICS CORPORATION For: 1 October By Investing.com (opens in a new tab)

  Investing.com Canada · Oct 1, 2026

• United Therapeutics Corp Stock (UTHR) Moved Up by 7.26% on Oct 1: What Investors Need To Know (opens in a new tab)

  TradingKey · Oct 1, 2026

• Accenture, Synopsys and United Therapeutics lead midday stock moves (opens in a new tab)

  Traders Union · Oct 1, 2026

• This United Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday (opens in a new tab)

  Benzinga · Oct 1, 2026

• UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% (opens in a new tab)

  TradingView · Oct 1, 2026

• Why is United Therapeutics stock gaining today? By Investing.com (opens in a new tab)

  Investing.com Australia · Oct 1, 2026

• United Therapeutics Wins Yutrepia Patent Infringement Ruling (opens in a new tab)

  grafa.com · Oct 1, 2026

• BTIG Upgrades United Therapeutics to Buy From Neutral, Price Target is $728 (opens in a new tab)

  marketscreener.com · Oct 1, 2026

• United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last? (opens in a new tab)

  Yahoo Finance Singapore · Oct 1, 2026

• United Therapeutics Wins Patent Lawsuit Against Liquidia (opens in a new tab)

  marketscreener.com · Oct 1, 2026

• United Therapeutics (UTHR) Stock Jumps 13% After Crushing Court Win Over Rival (opens in a new tab)

  CoinCentral · Oct 1, 2026

• United Therapeutics Soars 13% as Court Rules Yutrepia Infringes Its Patent (opens in a new tab)

  TIKR.com · Oct 1, 2026

• United Therapeutics Corporation wins Yutrepia PH‑ILD patent ruling (opens in a new tab)

  Mugglehead Investment Magazine · Oct 1, 2026

• Why Is United Therapeutics (UTHR) Stock Rocketing Higher Today (opens in a new tab)

  Yahoo Finance · Sep 30, 2026

• United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia (opens in a new tab)

  Yahoo Finance · Sep 30, 2026

• Liquidia slumps after US court rules for United Therapeutics in patent fight (opens in a new tab)

  Reuters · Sep 30, 2026

• United Therapeutics (UTHR) Rallies On Tyvaso Win And Massive Buyback (opens in a new tab)

  timothysykes.com · Sep 30, 2026

• A CEO’s trust exercises options and sells 9,500 United Therapeutics (UTHR) shares under a trading plan. (opens in a new tab)

  Stock Titan · Sep 30, 2026

• United Therapeutics jumps 13% on court ruling (UTHR:NASDAQ) (opens in a new tab)

  Seeking Alpha · Sep 30, 2026

• UTHR Stock Jumps As Tyvaso Win And Massive Buyback Fuel Momentum (opens in a new tab)

  StocksToTrade · Sep 30, 2026

• United Therapeutics Stock Analysis: 12% Intraday Surge Sparks Debate (opens in a new tab)

  The Cryptonomist · Sep 30, 2026

• United Therapeutics stock rises nearly 13% as FDA accepts supplemental Tyvaso application (opens in a new tab)

  Traders Union · Sep 30, 2026

• Liquidia plunges after court ruling in United Therapeutics patent fight (LQDA:NASDAQ) (opens in a new tab)

  Seeking Alpha · Sep 30, 2026

• Liquidia Corporation Announces District Court Ruling on United Therapeutics Patent Claims for YUTREPIA (opens in a new tab)

  Quiver Quantitative · Sep 30, 2026

• United Therapeutics (UTHR) Stock Pops On Tyvaso IPF Catalyst And Massive Buyback (opens in a new tab)

  StocksToTrade · Sep 30, 2026

• United Therapeutics (UTHR) Rallies On Tyvaso Catalyst And Big Buyback (opens in a new tab)

  timothysykes.com · Sep 30, 2026

• Midday Movers: ImmunityBio and United Therapeutics Lead Gains as Liquidia Tumbles (opens in a new tab)

  Business Upturn · Sep 30, 2026